1. Introduction {#sec1}
===============

The mushroom Scarlet elf cup (*Sarcoscypha coccinea*) is an edible fungus, even though it remains rather tough after cooking. It can be collected in Hungary in the Pécs area in the western Mecsek mountains and in the Zselic during February and March. To our knowledge the carotenoid composition of this mushroom has not been investigated and described to date in the literature.

The novelty and the main goal of our work is the determination of the carotenoid composition of the mushroom Scarlet elf cup (*Sarcoscypha coccinea*) by HPLC and CLC, the isolation of its main carotenoids \[(all-*E*, 2′*R*)-plectaniaxanthin (**1**) and (all-*E*)-2′-dehydroplectaniaxanthin (**2**); [Fig. 1](#fig1){ref-type="fig"}\] in highly pure crystalline state, the stucture elucidation of these carotenoids by spectroscopic methods (UV/Vis, ^1^H- and ^13^C-NMR, MS, IR), and the isolation of numerous sterically unhindered (*Z*)-isomers of **1** and **2**, and their identification on the basis of their UV/Vis spectroscopic properties. The secondary objective of this study is the confirmation of the (2′*R*) configuration of the naturally occurring (all-*E*)-plectaniaxanthin (**1**).Fig. 1Structure of (all-*E*, 2′*R*)-plectaniaxanthin (**1**) and of (all-*E*)-2′-dehydroplectaniaxanthin (**2**).Fig. 1

Plectaniaxanthin \[(all-*E*, 2′*R*)-3′,4′-didehydro-1′,2′-dihydro-β,ψ-carotene-1′,2′-diol; **1**\] and its mono- and diester have been isolated for the first time from the mushroom *Plectania coccinea* ([@bib3],[@bib4]) and its occurrence was subsequently demonstrated in several other mushrooms, as well ([@bib5]).

*Plectania coccinea* and *Sarcoscypha coccinea* are the same species; they are taxonomic synonyms ([@bib17]; [@bib30]; [http://www.mycobank.org/BioloMICS.aspx?TableKey=14682616000000067&Rec=21926&Fields=All](http://www.mycobank.org/BioloMICS.aspx?TableKey=14682616000000067&Rec=21926&Fields=Al){#intref0010}).

The constitution of the compound has been determined using spectroscopic methods (UV/Vis, IR, NMR, MS) ([@bib3],[@bib4]; [@bib14], [@bib15]; [@bib13]; [@bib33]; [@bib2]; [@bib5]; [@bib9]), however the configuration at C(2') of the isolated compound remained unknown for a long time. On the basis of CD spectroscopic studies carried out in 1982, it was possible to deduce to the (*R*) configuration ([@bib30]).

The (2′*R*) configuration has been verified in 1984: The total synthesis of (2′*S*)-plectaniaxanthin was reported, using L-serine as starting material, and based on the comparison of the CD spectra of the natural and the synthetic compound, the (2′*R*)-configuration of the natural compound was established ([@bib10]). The (2′*R*)-configuration has been confirmed by the result of later investigation ([@bib29]). The natural occurrence of the free (2′*S*)-plectaniaxanthin has not been reported to date, but its glucoside \[phleixanthophyll; (2′*S*)-1'-(β-D-glucopyranosyloxy)-3′,4′-didehydro-1′,2′-dihydro-β,ψ-caroten-2′-ol\] occurs in nature ([@bib14]; [@bib29]; [@bib8]).

The above mentioned studies reported also the isolation of 2′-dehydroplectaniaxanthin \[(all-*E*)-1′-hydroxy-3′,4′-didehydro-1′,2′-dihydro-β,ψ-caroten-2′-one; **2**\] and its esters.

2. Materials and methods {#sec2}
========================

2.1. General experimental procedures {#sec2.1}
------------------------------------

All chemicals used in the extraction, in column liquid chromatography (CLC) and during HPLC analysis were analytical grade quality (Sigma-Aldrich Ltd., Budapest, Hungary).

The UV/Vis spectra were recorded with a Beckman DU-65 spectrophotometer in toluene.

The NMR experiments were carried out on a Varian Unity Inova 400-WB spectrometer, at 400 MHz (^1^H) or 100 MHz (^13^C), in CDCl~3~ (99.8 atom% D; purchased from VWR International) at a probe temperature of 298K. Chemical shift values (δ) are given in ppm referenced to (CH~3~)~4~Si (^1^H) or the residual solvent signals (^13^C) ([@bib22], [@bib27]).

FT-IR spectrum was recorded on an IMPACT 400 spectrometer (Nicolet Analytical Instruments, 5225-1 Verona Road, P.O. Box 4508, Madison, WI 53711-0508, USA; DTGS detector; Δν 400--4000 cm^−1^; resolution 4 cm^−1^) in KBr pellets ([@bib18],[@bib19]; [@bib22], [@bib27]).

Mass spectra were recorded using a Varian MA--CH--7A mass spectrometer ([@bib22], [@bib27]).

2.2. HPLC measurements {#sec2.2}
----------------------

The HPLC separation of the extract of mushroom was performed on a Chromsyl C~18~ (6μm; end-capped) column (250 × 4.6 mm i. d.; 298K), using Dionex 580 pump, HP 1050 detector with ChemStation software; detection wavelength was 450 nm. Gradient elution (in linear steps, and flow rate of 1.25 ml/min) was used with solvents A (H~2~O/MeOH 12 : 88), B (MeOH), and C (acetone/MeOH 1 : 1): 0--2 min, 100% A; 2--10 min, to A/B 80 : 20; 10--18 min, to A/B 50 : 50; 18--25 min, to 100% B; 25--27 min, 100% B; 27--34 min, to 100% C, 34--41 min, 100% C ([@bib22], [@bib27]; [@bib16]; [@bib1]). The peak area was used to determine the percentage of individual components in the extract ([@bib28]).

The chiral HPLC separation of the racemic mixture of plectaniaxanthin enantiomers and a co-chromatography of this mixture with the natural (all-*E*, 2′*R*)-plectaniaxanthin (**1**) was carried out on a Chiralcel OD (3μm) column \[Daicel, Chemical Industries Ltd.; 250 × 4.6 mm i. d.; 303K (thermostated)\]. The sample was dissolved in MeOH. Isocratic elution (flow rate of 0.7 ml/min) was used with solvents A (*n*-hexane) and B (abs. EtOH): 0--40 min, 5.5% B. The analysis was performed with a Dionex HPLC system (Thermo Fischer Scientific) ([@bib32]).

2.3. Extraction {#sec2.3}
---------------

The freshly collected mushroom Scarlet elf cup (2500g) was homogenized with MeOH and extracted three times with MeOH and once with diethyl ether (Et~2~O). The three MeOH extracts and the ethereal extract were combined, transferred to a separatory funnel and diluted with Et~2~O. The ethereal phase was washed free from MeOH with water and dried over anhydrous Na~2~SO~4~. This solution was saponified with 30% KOH--MeOH at room temperature overnight (for 18 h). After this process the ethereal solution was washed free from alkali, evaporated to dryness under vacuum and dissolved in benzene. This solution was stored in darkness under nitrogen at --20 °C until further chromatographic separations ([@bib25]; [@bib31]; [@bib26]; [@bib23]; [@bib22], [@bib27]; [@bib16]).

2.4. Column liquid chromatography (CLC) {#sec2.4}
---------------------------------------

CaCO~3~ (Ph. Hg. VI., Biogal, Hungary) was used as adsorbent (size of the columns 6 × 30 cm), and the solvents *n*-hexane, 5--10% toluene in *n*-hexane and 0.1--0.5% acetone in *n*-hexane were used as eluents ([@bib25]).

3. Results and discussion {#sec3}
=========================

The HPLC analysis of the saponified total extract of the mushroom gave the following carotenoids in order of their decreasing polarity: (all-*E*)-plectaniaxanthin (**1**), (*Z*)-isomers of plectaniaxanthin (all-*E*)-2′-dehydroplectaniaxanthin (**2**), (*Z*)-isomers of 2′-dehydro-plectaniaxanthin, an unidentified carotenoid, β-carotene, and (*Z*)-isomers of β-carotene ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2HPLC analysis of the saponified total extract of mushroom Scarlet elf cup (*Sarcoscypha coccinea*).Fig. 2

During the preparative column liquid chromatography (CLC) ([@bib25]) of the saponified total extract the following carotenoids were isolated in order of their decreasing adsorption affinity: (all-*E*)-plectaniaxanthin (**1**), (13*Z*)-plectaniaxanthin \[(13*Z*)-**1**\], (13′*Z*)-plectaniaxanthin \[(13′*Z*)-**1**\], (9*Z*)-2′-dehydroplectaniaxanthin \[(9*Z*)-**2**\], (13*Z*)-2′-dehydroplectaniaxanthin \[(13*Z*)-**2**\], (13′*Z*)-2′-dehydroplectaniaxanthin \[(13′*Z*)-**2**\], (15*Z*,5′*Z*(?))-2′-dehydroplectaniaxanthin \[(15*Z*,5′*Z*(?))-**2**\], (15*Z*)-plectaniaxanthin \[(15*Z*)-**1**\], (15*Z*)-2′-dehydroplectaniaxanthin \[(15*Z*)-**2**\], (all-*E*)-2′-dehydroplectaniaxanthin (**2**), (9*Z*,9′*Z*)-2′-dehydroplectaniaxanthin \[(9*Z*,9′*Z*)-**2**\], (9′*Z*)-2′-dehydroplectaniaxanthin \[(9′*Z*)-**2**\], (9*Z*,5′*Z*)- or (9′*Z*,5′*Z*)-2-dehydroplectaniaxanthin \[(9*Z*,5′*Z*)-**2** or (9′*Z*,5′*Z*)-**2**\], β-carotene ([Table 1](#tbl1){ref-type="table"}) (all-*E*)-Plectaniaxanthin (**1**; 25 mg) and (all-*E*)-2′-dehydroplectaniaxanthin (**2**, 21 mg) were isolated in a pure crystalline state (m.p. of **1**: 175--176 °C; m. p. of **2**: 146--148 °C) and were identified by UV/Vis spectroscopy, ^1^H- and ^13^C-NMR spectroscopy and mass spectrometry. The UV/Vis data are shown in [Table 1](#tbl1){ref-type="table"}.Table 1Preparative column chromatography of the saponified total extract of mushroom Scarlet elf cup (*Sarcoscypha coccinea*); UV/Vis data of the isolated carotenoids.Table 1Zoneλ~max~ (nm, toluene)Q[∗](#tbl1fnlowast){ref-type="table-fn"}Carotenoid111523, 489, 462, 37612.3(all-*E*)-Plectaniaxanthin132515, 483, 457, 3742.3(13*Z*)- or (13′*Z*)-Plectaniaxanthin143515, 482, 457, 3732.2(13′*Z*)- or (13*Z*)-Plectaniaxanthin151512, 4075.4(9*Z*)- or (9′*Z*)-Dehydroplectaniaxanthin152505, 4001.8(13*Z*)- or (13′*Z*)-Dehydroplectaniaxanthin222511, 4012.0(13′*Z*)- or (13*Z*)-Dehydroplectaniaxanthin23496, 4072.5(poly-*Z*)-Dehydroplectaniaxanthin241510, 4001.6(15*Z*)-Dehydroplectaniaxanthin243515, 483, 458, 3741.6(15*Z*)-Plectaniaxanthin31518, 4074.9(all-*E*)-Dehydroplectaniaxanthin32503, 4082.8(9*Z*,9′*Z*)-Dehydroplectaniaxanthin4511, 4064.9(9′*Z*)- or (9*Z*)-Dehydroplectaniaxanthin5507, 4032.7(di-*Z*)-Plectaniaxanthin6493, 464\>10β-Carotene[^2][^3]

The UV/Vis spectra of (all-*E*)-plectaniaxanthin (1) together with the spectra of its three main (mono-*Z*)-isomers \[(13*Z*)-1, (13′*Z*)-1 and (15*Z*)-1\], and the UV/Vis spectra of (all-*E*)-2-dehydroplectaniaxanthin (2) together with its four main (mono-*Z*)-isomers \[(9*Z*)-2, (9′*Z*)-2 (13*Z*)-2 (13′*Z*)-2\] are indicated, as examples on Figs. [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}.Fig. 3UV/Vis spectra of (all-*E*)-plectaniaxanthin (**1**) and of its (13*Z*) and (13′*Z*) isomers.Fig. 3Fig. 4UV/Vis spectra of (all-*E*)-plectaniaxanthin (**1**) and of its (15*Z*)) isomer.Fig. 4Fig. 5UV/Vis spectra of (all-*E*)-2′-dehydroplectaniaxanthin (**2**) and of its (9*Z*) and (9′Z) isomers.Fig. 5Fig. 6UV/Vis spectra of (all-*E*)-2′-dehydroplectaniaxanthin (**2**) and of its (13*Z*) and (13′Z) isomers.Fig. 6

The UV/Vis spectroscopic properties (λ~max~-values, fine sructure) of (all-*E*)-**1** and (all-*E*)-**2** were in agreement with the correponding data in the literature ([@bib5]; [@bib30]; [@bib7]; [@bib8]) confirming the characteristic chromophors (3′,4′-didehydro-1′,2′-dihydro-β,ψ-carotene, 3′,4′-didehydro-1′,2′-dihydro-β,ψ-caroten-2′-one respectively) of these carotenoids.

The (*Z*)-isomers of plectaniaxanthin (**1**) and 2′-dehydroplectaniaxanthin (**2**) have not been isolated from natural sources to date. The crystallization of the majority of these isomers was unsuccessful because of their small quantity and special solubility, therefore their structure and geometrical configuration was deduced from their UV/Vis spectroscopic properties (λ~max~-shifts; Q = A~max~/A~*cis*-peak~; [Table 1](#tbl1){ref-type="table"}, Figs. [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}) ([@bib34]; [@bib7]; [@bib21]).

The ^13^C-NMR measurements of the naturally occurring (all-*E*)-plectaniaxanthin (**1**) and (all-*E*)-2′-dehydroplectaniaxanthin (**2**) were carried out for the first time in our laboratory. The ^1^H- and ^13^C-NMR chemical shifts are summarized in [Table 2](#tbl2){ref-type="table"}. The ^1^H-NMR chemical shifts of the (all-*E*)-plectaniaxanthin (1), isolated in our laboratory showed a good agreement with that of the natural (2′*R*)- and of the synthetic (2′*S*)-plectaniaxanthin, published earlier ([@bib15]; [@bib5]; [@bib10]; [@bib20]); The ^1^H- and ^13^C-NMR chemical shifts of naturally occurring (all-*E*)-plectaniaxanthin (1) and of (all-*E*)-2′-dehydroplectaniaxanthin (2) showed also a good agrement with the chemical shifts, which were published for the corresponding end groups ([@bib2]; [@bib11]).Table 2^1^H- and^13^C-NMR chemical shifts (δ in ppm) of (all-*E*)-plectaniaxanthin (**1**) and of (all-*E*)-2′-dehydroplectaniaxanthin (**2**) in CDCl~3~.Table 2(all-*E*)-Plectaniaxanthin (1)(all-*E*)-2′-Dehydroplectaniaxanthin (2)C-atom^1^H^13^CC-atom^1^H^13^C1-34.21**-**34.321.4639.521.4539.731.6119.131.6019.34.01232.9433.15-129.45-129.46-137.86-137.976.17126.776.18126.986.12137.786.12137.79-136.09-136.1106.14130.8106.14130.8116.65125.1116.66125.5126.34137.1126.34137.113-?13**--**146,23133.2146.24135.4156.63130.2130.2156.66131.1161.0228.7161.0229.0171.0228.7171.0229.0181.7121.5181.7121.8191.9612.8191.9912.8201.9615.8201.9712.81′-73.11′-75.32′3.9979.92′-202.43′5.70126.23′6.41116.14′6.37138.14′7.56150.05′-134.05′-133.06′6.19132.96′6.60142.57′6.58124.27′6.59123.68′6.38138.58′6.67143.39′-?9′-137.310′6.24132.410′6.35136.211′6.61124.811′6.42124.612′6.38138.212′6.45140.113′-?13′-136.414′6.27133.214′6.31134.415′6.63130.015′6.63129.7\
16′1.2326.316′1.4126.817′1.1723.817′1.4126.818′1.9112.818′1.9712.819′1.9612.619′1.9712.820′1.9612.620′1.9712.8

The MS data of (all-*E*)-plectaniaxanthin (1) were in accordance with literature data ([@bib13]; [@bib5]; [@bib10]; [@bib12]; [@bib8]). The peak of molecular ion was observed at *m*/*z* 568 (M^+^, C~40~H~56~O~2~), together with fragments at *m*/*z* 552 (\[M-O\]^+^), 550 (\[M-H~2~O\]^+^), 534 (\[M--H~2~O--O\]^+^), 532 (\[M-2H~2~O\]^+^), 510 (\[M-CH~3~COCH~3~\]^+^), 508 (\[M-CH~3~CHOHCH~3~\]^+^), 476 (\[M-C~6~H~5~CH~3~\]^+^), 462 (\[M-C~6~H~4~(CH~3~)~2~\]^+^), 444 (\[M--C~6~H~4~(CH~3~)~2~--H~2~O\]^+^), 428 (\[M--C~6~H~4~(CH~3~)~2~--H~2~O--O\]^+^), 404 (\[M--C~6~H~4~(CH~3~)~2~--CH~3~COCH~3~\]^+^), 403 (\[M--C~6~H~4~(CH~3~)~2~--CH~3~COCH~3~--H\]^+^), 402 (\[M--C~6~H~4~(CH~3~)~2~--CH~3~CHOHCH~3~\]^+^), 209, 197, 171, 157, 145, 119,105, 95, 81, 59, 57, 43.

The MS spectrum of (all-*E*)-2′-dehydroplectaniaxanthin (2) resulted in the following fragment ions, which were in accordance with the data in the literature ([@bib13]; [@bib33]; [@bib2]; [@bib12]; [@bib8]); *m*/*z*: 566 (\[M^+^; C~40~H~54~O~2~\]), 550 (\[M-O\]^+^), 548 (\[M-H~2~O\]^+^), 507 (\[M--CH~3~COCH~3~--H\]^+^), 474 (\[M-C~6~H~5~CH~3~\]^+^), 460 (\[M-C~6~H~4~(CH~3~)~2~\]^+^), 368 (\[M--C~6~H~4~(CH~3~)~2~--C~6~H~5~CH~3~\]^+^), 209, 197, 183, 145, 119, 105, 95, 81, 69, 59, 43.

In the FT-IR spectrum of (all-*E*)-2′-dehydroplectaniaxanthin (2) the band ν = 1668 cm^−1^ (very strong C = O stretching frequency absorption) is characteristic to the 2′-keto group conjugated with the polyene chain ([@bib3],[@bib4]; [@bib14]; [@bib18], [@bib19]; [@bib22], [@bib27]; [@bib6]).

The NaBH~4~ reduction of (all-*E*)-2′-dehydroplectaniaxanthin (2) resulted in the formation of the racemic mixture of (*R*)- and (*S*)-plectaniaxanthin verifying the presence of the conjugated 2′-keto group ([@bib3],[@bib4]; [@bib8]).

The racemic mixture of plectaniaxanthin enantiomers was separated by HPLC using „Chiralcel OD" column ([Fig. 7](#fig7){ref-type="fig"}) ([@bib32]). The co-chromatography of the racemic mixture with the natural (all-*E*, 2′*R*)-plectaniaxanthin proved the identity of **peak 1** with this carotenoid and of **peak 2** with the corresponding (2′*S*)-enantiomer.Fig. 7HPLC separation of the racemic mixture of plectaniaxanthin enantiomers.Fig. 7

HPLC-ECD measurements were also carried out by stopping the eluent in the HPLC flow cell ([@bib32]), but distinct ECD spectra could not be recorded for the separated enantiomers at room temperature, which may be due to the conformational flexibility of plectaniaxanthin.

4. Conclusion {#sec4}
=============

In this study, we described the determination of the carotenoid composition of the mushroom Scarlet elf cup (*Sarcoscypha coccinea*) by HPLC and CLC, the determination of the ^13^C-NMR chemical shifts of the naturally occurring (all-*E*)-plectaniaxanthin (**1**) and (all-*E*)-2′-dehydroplectaniaxanthin (**2**), and the isolation and partial characterization of three sterically unhindered mono-*cis* isomers of plectaniaxanthin (**1**) \[(13*Z*)-**1**, (13′*Z*)-**1** and (15*Z*)-**1**\], five mono-*cis* isomers of 2′-dehydroplectaniaxanthin (**2**) \[(9*Z*)-**2**, (9′*Z*)-**2** (13*Z*)-**2**, (13′*Z*)-**2** and (15*Z*)-**2**\], three di-*cis* isomers of 2′-dehydroplectaniaxanthin (**2**) \[(9*Z*,5′*Z*)-**2** or (9′*Z*,5′*Z*)-**2**, and probably (15*Z*,5′*Z*)-**2**\], and one poly-*cis* (tri-*cis*) isomer of 2′-dehydroplectaniaxanthin (**2**) \[probably (9*Z*,9′*Z*,5′*Z*)-**2**\], for the first time. The main carotenoids \[(all-*E*)-plectaniaxanthin (**1**) and (all-*E*)-2′-dehydroplectaniaxanthin (**2**)\] were isolated in highly pure crystalline state. The structure elucidation of these carotenoids was carried out by spectroscopic methods (UV/Vis, ^1^H- and ^13^C-NMR, MS, IR). The majority of the isolated (*Z*) isomers were identified and characterized only on the basis of their UV/Vis spectroscopic properties \[λ~max~-shifts; Q-values (Q = A~max~/A~*cis*-peak~)\] ([@bib34]; [@bib7]; [@bib21]; [@bib24]).

Besides of the main achivements of our work mentioned above, the (2′*R*)-configuration of the naturally occurring (all-*E*)-plectaniaxanthin (**1**) was also confirmed.
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